Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (238)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
59
2024
2958
4.170
Why?
Hematopoietic Stem Cell Transplantation
9
2024
567
1.130
Why?
Antibodies, Bispecific
5
2024
69
1.030
Why?
Leukemia, Plasma Cell
2
2020
33
0.880
Why?
Immunotherapy, Adoptive
5
2024
159
0.740
Why?
Bone Marrow
10
2022
363
0.710
Why?
Neoplasms, Plasma Cell
3
2024
37
0.660
Why?
Plasma Cells
6
2023
223
0.600
Why?
Humans
68
2024
50251
0.600
Why?
Chromosome Deletion
2
2023
140
0.600
Why?
Transplantation, Autologous
10
2024
470
0.580
Why?
Chromosomes, Human, Pair 17
1
2017
36
0.570
Why?
Gene Expression Profiling
10
2023
1041
0.550
Why?
Tumor Suppressor Protein p53
2
2017
203
0.550
Why?
Clinical Trials as Topic
4
2022
466
0.530
Why?
Gene Expression Regulation, Neoplastic
6
2021
828
0.520
Why?
Neoplasm, Residual
6
2022
165
0.500
Why?
Proteasome Inhibitors
1
2016
104
0.500
Why?
Immunologic Factors
1
2016
114
0.490
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
115
0.490
Why?
B-Cell Maturation Antigen
6
2024
91
0.480
Why?
Prognosis
15
2024
1959
0.460
Why?
Immunotherapy
1
2016
240
0.450
Why?
Stem Cell Transplantation
5
2024
181
0.450
Why?
Translocation, Genetic
5
2021
264
0.440
Why?
Aged
22
2024
9427
0.440
Why?
Antibodies, Monoclonal
2
2022
461
0.440
Why?
Mutation
7
2022
1296
0.430
Why?
Neoplasm Proteins
4
2020
324
0.410
Why?
Neutropenia
2
2023
115
0.400
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.390
Why?
Neoplasms
2
2012
1250
0.390
Why?
Lymphocytes
1
2012
153
0.380
Why?
Cancer Vaccines
1
2011
78
0.360
Why?
Evolution, Molecular
2
2021
99
0.360
Why?
Neoplasm Recurrence, Local
7
2024
633
0.350
Why?
Positron-Emission Tomography
4
2022
293
0.350
Why?
Survival Analysis
7
2021
666
0.340
Why?
Diffusion Magnetic Resonance Imaging
3
2019
124
0.340
Why?
Cytokines
1
2012
615
0.320
Why?
Tumor Microenvironment
3
2024
233
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
994
0.300
Why?
Hematologic Neoplasms
2
2022
99
0.300
Why?
Female
26
2024
26668
0.290
Why?
Middle Aged
20
2024
12234
0.280
Why?
Atrial Fibrillation
2
2022
184
0.280
Why?
Combined Modality Therapy
4
2024
641
0.280
Why?
Aged, 80 and over
8
2024
3140
0.260
Why?
Male
24
2024
25483
0.250
Why?
Fluorodeoxyglucose F18
4
2021
194
0.240
Why?
Proto-Oncogene Proteins B-raf
3
2020
79
0.240
Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
Why?
Adult
16
2024
13384
0.230
Why?
Neoplasms, Second Primary
1
2024
78
0.220
Why?
Treatment Outcome
8
2024
5186
0.220
Why?
Chromosomes, Human, Pair 1
2
2023
93
0.210
Why?
Disease Progression
6
2021
827
0.210
Why?
Paraproteinemias
1
2022
72
0.200
Why?
Immunoconjugates
1
2022
39
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Recurrence
6
2024
661
0.200
Why?
Lymphoma, B-Cell
1
2022
63
0.200
Why?
Epigenomics
1
2021
68
0.190
Why?
Patient Participation
1
2022
67
0.190
Why?
T-Lymphocytes
4
2024
339
0.190
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Practice Guidelines as Topic
1
2023
452
0.180
Why?
Cell Cycle
1
2021
232
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
Why?
Risk Factors
8
2021
3608
0.170
Why?
Bone Resorption
1
2022
302
0.170
Why?
Bone Diseases
1
2021
99
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Disease-Free Survival
5
2019
454
0.170
Why?
Antigens, CD
1
2020
221
0.170
Why?
Healthcare Disparities
1
2022
270
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Spleen
1
2019
172
0.160
Why?
Spinal Fractures
1
2018
37
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Brain Neoplasms
2
2011
289
0.150
Why?
Antineoplastic Agents
2
2024
1186
0.150
Why?
Bacteremia
1
2019
91
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Gene Rearrangement
1
2018
74
0.150
Why?
Retrospective Studies
7
2024
6172
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Retinoblastoma Binding Proteins
1
2017
10
0.140
Why?
Calcification, Physiologic
1
2017
41
0.140
Why?
Epigenesis, Genetic
1
2020
378
0.140
Why?
Pelvis
1
2017
67
0.140
Why?
Survival Rate
4
2020
902
0.140
Why?
Cell Proliferation
4
2023
1015
0.140
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
106
0.140
Why?
Immunoglobulin Light Chains
1
2017
82
0.140
Why?
Ubiquitin-Protein Ligases
1
2017
96
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Flow Cytometry
1
2018
478
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.130
Why?
Gene Expression
1
2018
615
0.130
Why?
Animals
4
2024
13285
0.120
Why?
Cystatin M
2
2024
20
0.110
Why?
Cross-Sectional Studies
3
2023
1557
0.110
Why?
Cardiovascular Diseases
1
2017
442
0.100
Why?
Follow-Up Studies
3
2024
2180
0.100
Why?
Astrocytoma
1
2011
20
0.100
Why?
Lymphoma, Non-Hodgkin
1
2011
59
0.100
Why?
Mutation Rate
2
2021
36
0.090
Why?
Glioma
1
2011
79
0.090
Why?
Disease Models, Animal
1
2016
1470
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
259
0.090
Why?
Alleles
2
2021
250
0.090
Why?
Genomics
2
2023
287
0.090
Why?
Remission Induction
2
2021
207
0.090
Why?
Tumor Burden
2
2020
131
0.090
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
66
0.080
Why?
Vaccination
1
2011
273
0.080
Why?
Histones
2
2021
313
0.080
Why?
Transcription Factors
2
2023
564
0.080
Why?
DNA Copy Number Variations
2
2021
110
0.080
Why?
Radiopharmaceuticals
2
2021
208
0.080
Why?
Models, Biological
1
2011
726
0.080
Why?
Cell Differentiation
2
2022
652
0.070
Why?
Transcriptome
2
2020
320
0.070
Why?
Kaplan-Meier Estimate
2
2019
465
0.070
Why?
Imaging, Three-Dimensional
2
2017
153
0.060
Why?
Biopsy
2
2018
591
0.060
Why?
Arkansas
2
2021
1962
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Killer Cells, Natural
1
2024
108
0.060
Why?
Demography
1
2024
93
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
127
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
Antibodies
1
2024
155
0.060
Why?
Mice
2
2024
5770
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Signal Transduction
2
2021
1624
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
252
0.050
Why?
United States Food and Drug Administration
1
2022
92
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Bone Marrow Transplantation
1
2022
116
0.050
Why?
Dexamethasone
1
2024
431
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Clone Cells
1
2021
78
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.050
Why?
Chromatin
1
2021
152
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Pyrimidines
1
2022
194
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Genome, Human
1
2021
111
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
207
0.040
Why?
DNA, Neoplasm
1
2020
147
0.040
Why?
Health Status Disparities
1
2022
195
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
171
0.040
Why?
Multivariate Analysis
1
2021
578
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Cell Line, Tumor
1
2023
1418
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
Why?
Computational Biology
1
2020
216
0.040
Why?
Pseudomonas Infections
1
2019
49
0.040
Why?
Syndrome
1
2019
239
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
428
0.040
Why?
Promoter Regions, Genetic
1
2020
475
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Oncogene Proteins, Fusion
1
2018
58
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
Retinoblastoma Protein
1
2017
19
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
STAT3 Transcription Factor
1
2017
81
0.040
Why?
Fibroblast Growth Factors
1
2017
47
0.040
Why?
Bone and Bones
1
2021
475
0.040
Why?
Glomerular Filtration Rate
1
2017
110
0.040
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.040
Why?
Amino Acid Sequence
1
2018
587
0.030
Why?
Alkaline Phosphatase
1
2017
95
0.030
Why?
Sequence Analysis, DNA
1
2017
238
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
NF-kappa B
1
2018
316
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
DNA Methylation
1
2020
550
0.030
Why?
Models, Genetic
1
2016
170
0.030
Why?
Genomic Instability
1
2016
93
0.030
Why?
Staphylococcal Infections
1
2019
269
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Logistic Models
1
2018
891
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Melphalan
1
2016
174
0.030
Why?
Heart
1
2017
331
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Algorithms
1
2018
618
0.030
Why?
Echocardiography
1
2017
373
0.030
Why?
Time Factors
1
2021
2911
0.030
Why?
Myocardium
1
2017
439
0.030
Why?
Disease Management
1
2015
176
0.030
Why?
Longitudinal Studies
1
2016
687
0.030
Why?
Thalidomide
1
2016
377
0.030
Why?
Risk Assessment
1
2018
1257
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1377
0.030
Why?
Ifosfamide
1
2011
9
0.020
Why?
Dacarbazine
1
2011
9
0.020
Why?
Carboplatin
1
2011
53
0.020
Why?
Tomography, X-Ray Computed
1
2017
1169
0.020
Why?
Etoposide
1
2011
72
0.020
Why?
United States
1
2022
4887
0.020
Why?
Treatment Failure
1
2011
116
0.020
Why?
Fatal Outcome
1
2011
196
0.020
Why?
Drug Administration Schedule
1
2011
374
0.020
Why?
Magnetic Resonance Imaging
1
2017
1542
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description